Try a FREE Board Survey and get a Benchmarked Report - Click Here
Clinical governance is one of the most critical responsibilities for boards overseeing health, aged care, disability, and community services. Yet despite its importance, clinical governance is often misunderstood, under-examined, or overly delegated.
For most boards, detailed oversight of clinical governance sits with a Clinical Governance Committee. When that committee is effective, it strengthens board assurance and supports safer, higher-quality care. When it is not, boards may be exposed to significant clinical and reputational risk — often without realising it.
This article outlines what clinical governance committee effectiveness means, why it matters, and how it supports strong board clinical governance.
Clinical governance is the framework through which organisations are accountable for the quality, safety, and continuous improvement of clinical care.
At a board level, clinical governance is not about managing clinical operations. It is about assurance — confidence that care is safe, risks are understood, and systems are working as intended.
Effective board clinical governance allows directors to answer key questions:
Clinical governance sits alongside financial, strategic, and risk governance. For boards overseeing clinical services, it is core governance business.
Most boards establish a Clinical Governance Committee (sometimes called a Quality and Safety Committee) to support oversight of clinical matters.
The committee’s role is not to manage care, but to:
In this way, the committee acts as a key assurance mechanism for board clinical governance.
Clinical governance committee effectiveness refers to how well the committee supports the board to fulfil its clinical governance responsibilities.
Effectiveness is not measured by the number of reports reviewed or meetings held. Instead, an effective committee:
In short, an effective committee strengthens board judgement and confidence.
Boards depend on committees to provide confidence that clinical risks are being identified and managed. If the committee is ineffective, board assurance may be misplaced.
Regulators and inquiries increasingly expect boards to demonstrate active oversight of clinical governance, including evidence of challenge, escalation, and follow-up.
Clinical failures can result in serious harm, loss of trust, and reputational damage. Effective committee oversight helps boards focus on what matters most, before issues escalate.
Across many organisations, similar challenges emerge:
These issues can dilute the committee’s value and weaken board clinical governance.
Effective committees demonstrate several consistent behaviours.
They prioritise key clinical risks, rather than trying to cover everything.
They ask better questions, testing assurance rather than accepting information at face value.
They use information, not just data, focusing on trends, exceptions, and outcomes.
They strengthen board oversight, providing clear insight, early warning of emerging risks, and practical advice for board consideration.
Clinical governance committee effectiveness is not just a governance issue — it directly affects the quality and safety of care people receive.
Boards that invest in effective clinical governance committees are better positioned to:
Clinical governance cannot be delegated away.
While management is responsible for delivering care, boards remain accountable for clinical governance. An effective Clinical Governance Committee is one of the most important tools boards have to meet that responsibility well.
When the committee is effective, board clinical governance is stronger, risks are clearer, and assurance is more meaningful — ultimately supporting better outcomes for the people the organisation exists to serve.
Board Benchmarking
Australia
Level 27, 367 Collins Street
Melbourne, Victoria 3000
PH: +61 3 9909 9295
Westlake Governance
New Zealand
PO Box 8052
Wellington 6140
New Zealand
PH: +64 21 443 137
Halex Consulting
United Kingdom
86-90 Paul Street London, EC2A 4NE
PH: +44 (0)20 3823 6569
Cornerstone
India
313 Gokul Arcade
Subhash Road,
Vile Parle East
Mumbai, 400057
PH: +91 981 907 7135
Peakstone Global
Australia
GPO Box 1486
Brisbane Queensland 4001
PH: 1300 860 450
Board Benchmarking
Malaysia
66 Jalan Ibrahim Johor Bahru
80000 Johor
PH: +60 1933 54731
BDO
Mauritius
10 Frère Félix de Valois
Port Louis
PH: +230 202 3000
Gaines Advisory
Australia
PO Box 610
Cottesloe WA 6011
PH: +61 414 633 230
BDO
Malaysia
360 Jalan Tuanku Abdul
Rahman
50100 Kuala Lumpur
PH: +603 2616 2888
Twafiika Consultants
Africa
20 Eugmbo Street
Windhoek
Namibia
PH: +264 81 287 2104